Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

Victoria Abbing‐Karahagopian(Utrecht University), Marie L. De Bruin, Mark de Groot(Utrecht University), Toine C. G. Egberts(Utrecht University), Consuelo Huerta(Agencia Española de Medicamentos y Productos Sanitarios), Hubert G. M. Leufkens(Utrecht University), Raymond G. Schlienger(Novartis (Switzerland)), Olaf H. Klungel(Utrecht University), Marietta Rottenkolber(Zimmer Biomet (Germany)), Robert F. Reynolds(Pfizer (United States)), Jim Slattery, Belén Oliva(Agencia Española de Medicamentos y Productos Sanitarios), Helga Gardarsdóttir(Utrecht University), Miguel Gil(Agencia Española de Medicamentos y Productos Sanitarios), Patrick C. Souverein(Utrecht University), Francisco J. de Abajo(Universidad de Alcalá), Liset van Dijk(University of Groningen), Frank de Vries(Utrecht University), Gema Requena(Universidad de Alcalá), Sven Schmiedl(Witten/Herdecke University), U. Hesse(Danish National Institute of Public Health), Tjeerd van Staa(Utrecht University)
European Journal of Clinical Pharmacology
May 2, 2014
Cited by 162


Related Papers